FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/038617 [Registered on: 14/12/2021] Trial Registered Prospectively
Last Modified On: 10/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Smartphone app for heart attack patients- A Clinical Trial  
Scientific Title of Study   Smartphone based application for drug adherence and risk factor modification in outpatients with coronary artery disease – an open label randomized controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Santhosh Satheesh 
Designation  Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Department of Cardiology JIPMER Pondicherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9443426244  
Fax    
Email  drsanthoshsatheesh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Santhosh Satheesh 
Designation  Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Department of Cardiology JIPMER Pondicherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9443426244  
Fax    
Email  drsanthoshsatheesh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Saurav Banerjee 
Designation  Senior Resident 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Department of Cardiology JIPMER Pondicherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9874657534  
Fax    
Email  bsaurav0206@gmail.com  
 
Source of Monetary or Material Support  
JIPMER Alumni Association of North America 
 
Primary Sponsor  
Name  JIPMER Alumni Association of North America 
Address  28072 Clima, Mission Viejo, CA 92692, USA 
Type of Sponsor  Other [Alumni Association of JIPMER] 
 
Details of Secondary Sponsor  
Name  Address 
Jawaharlal Institute of Postgraduate Medical Education and Research  Dhanvantari Nagar, Pondicherry 605006 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Santhosh Satheesh  Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER  Room Number: 5027, Cardiology OPD, Ground Floor, Super Specialty Block, JIPMER, Dhanvantari Nagar, Pondicherry- 605006.
Pondicherry
PONDICHERRY 
9443426244

drsanthoshsatheesh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JIPMER Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I259||Chronic ischemic heart disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Active App  Active App will be customised based on patient profile and risk factors; will actively interact with the patient through alerts, reminders and warnings, based on automatically captured data (steps per day, inactivity, sleep per day, clicks on stress and medication screens) and actively entered patient data weekly (Every Sunday- BP, HR, Blood sugars (for diabetics only), Diet Scoring, Smoking Scoring, Alcohol Scoring, Stress Scoring) 
Comparator Agent  Control App  Control App will only monitor and display steps walked and sleep data to the patient. Control patients will be given a diary to record their weekly BP HR and blood sugars (for diabetics). Both groups will receive guideline directed standard cardiac care. Follow up visits will be scheduled at 30 days interval till 180 days.  
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  64.00 Year(s)
Gender  Both 
Details  1. Patients with clinically documented stable CAD attending cardiology OPD of JIPMER hospital.
2. 18 years to 64 years
3. Able to use a smart phone with android function
4. Able to read English or Tamil
 
 
ExclusionCriteria 
Details  1. Recent ACS or PCI within 1 month
2. Patients awaiting revascularization
3. Has visual, auditory, cognitive or motor impairment
4. LVEF<35%
5. COPD, Peripheral Vascular Disease, Post Pacemaker
6. Recent CABG within 6 months.
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method and Medication adherence score.

Improvement of CV risk factor targets (defined before).
 
Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method.

Improvement of CV risk factor targets (defined before).
 
 
Secondary Outcome  
Outcome  TimePoints 
Change in Quality of Life, Stress level and Quality of sleep are the secondary outcomes measured at baseline, 12 weeks and 24 weeks 
 
Target Sample Size   Total Sample Size="178"
Sample Size from India="178" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/12/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None so far 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a Digital health intervention randomized controlled trial  analyzing  an Android smartphone application for achieving risk factor modification and medication adherence in stable coronary artery disease patients for six months.  
Close